Johnson & Johnson
JNJ
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the Read More...Read Less
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 6 hours ago • JNJ
Johnson & Johnson's TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBCGlobeNewsWire • 6 hours ago • JNJ
Johnson & Johnson's TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBCGlobeNewsWire • 6 hours ago • JNJ
Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate reported to date with sustained clinical benefits in patients with certain types of bladder cancerPRNewsWire • 6 hours ago • JNJ
Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in patients with certain types of bladder cancerThe Motley Fool • 10 hours ago • JNJ
These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.